These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36415347)

  • 1. Physiotherapy Management of an Adolescent With Pityriasis Rubra Pilaris Along With Rickets.
    Palkrit S; Chitale N; Phansopkar P; Deshmukh M
    Cureus; 2022 Oct; 14(10):e30518. PubMed ID: 36415347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Juvenile Pityriasis Rubra Pilaris: A Case Report of Early Onset With Late Diagnosis.
    Albrakati BA; Alshareef IA; Alhawsawi WK; Al Hawsawi KA
    Cureus; 2022 Oct; 14(10):e30234. PubMed ID: 36381776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatomyositis with a pityriasis rubra pilaris-like eruption: an uncommon cutaneous manifestation in dermatomyositis.
    Polat M; Lenk N; Ustün H; Oztaş P; Artüz F; Alli N
    Pediatr Dermatol; 2007; 24(2):151-4. PubMed ID: 17461814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
    Di Stefani A; Galluzzo M; Talamonti M; Chiricozzi A; Costanzo A; Chimenti S
    J Dermatol Case Rep; 2013 Mar; 7(1):5-9. PubMed ID: 23580907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis in a patient with pityriasis rubra pilaris.
    Frikha F; Frigui M; Masmoudi H; Turki H; Bahloul Z
    Pan Afr Med J; 2010 Aug; 6():6. PubMed ID: 21436949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pityriasis rubra pilaris with rickets: a rare clinical image.
    Shende S; Sharma R
    Pan Afr Med J; 2022; 42():285. PubMed ID: 36405665
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.
    Katharina M; Sylvia S; Matthias B; Ulrich M; Martin L
    Pediatr Dermatol; 2022 Jul; 39(4):659-661. PubMed ID: 35859269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
    Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
    J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Pityriasis Rubra Pilaris: A Case Report.
    MacGillivray ME; Fiorillo L
    J Cutan Med Surg; 2018; 22(6):624-626. PubMed ID: 29754526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis rubra pilaris: an unusual cutaneous complication of AIDS.
    Bonomo RA; Korman N; Nagashima-Whalen L; Briggs J; Graham R; Salata RA
    Am J Med Sci; 1997 Aug; 314(2):118-21. PubMed ID: 9258214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Management of Cicatricial Ectropion in Pityriasis Rubra Pilaris.
    Haridas AS; Sullivan TJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):e12-5. PubMed ID: 25794020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pityriasis rubra pilaris: a review of diagnosis and treatment.
    Cohen PR; Prystowsky JH
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):801-7. PubMed ID: 2654219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis rubra pilaris heralding diagnosis of urothelial carcinoma: a case report.
    Young PA; Rangel J; Keller LC
    Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic, Clinicopathologic, Diagnostic, and Management Challenges of Pityriasis Rubra Pilaris: A Case Series of 100 Patients.
    Ross NA; Chung HJ; Li Q; Andrews JP; Keller MS; Uitto J
    JAMA Dermatol; 2016 Jun; 152(6):670-5. PubMed ID: 26963004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis Rubra Pilar and hypothyroidism.
    Franzotti AM; Avelar JC; Cardoso TA; Pires MC; Vidigal Mdo R
    An Bras Dermatol; 2014; 89(3):497-500. PubMed ID: 24937828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pityriasis rubra pilaris post-infection due COVID-19: case report.
    Aguilar-Gamboa FR; Cubas-Alarcon D; Villegas-Chiroque M; Failoc-Rojas VE
    Colomb Med (Cali); 2021 Mar; 52(1):e7014577. PubMed ID: 33911322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
    Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
    JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab-induced pityriasis rubra pilaris-like eruption.
    Brown S; Fletcher JW; Fiala KH
    Proc (Bayl Univ Med Cent); 2016 Jul; 29(3):335-6. PubMed ID: 27365893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.